FTXH Holdings Information

FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Eli Lilly and Company stock at 7.75%, AbbVie at 7.21%, Johnson & Johnson at 6.98%, Merck & Co. at 6.76%, and Bristol-Myers Squibb Company at 6.22%.

Total Holdings

Top 10 Percentage

51.96%

Asset Class

Equity

ETF Category

Health

Assets

34.19M

PE Ratio

21.46

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.75%	2,347
2	ABBV	AbbVie Inc.	7.21%	10,640
3	JNJ	Johnson & Johnson	6.98%	9,939
4	MRK	Merck & Co., Inc.	6.76%	19,942
5	BMY	Bristol-Myers Squibb Company	6.22%	39,590
6	VTRS	Viatris Inc.	3.66%	82,694
7	BIIB	Biogen Inc.	3.47%	6,436
8	CAH	Cardinal Health, Inc.	3.41%	5,386
9	VRTX	Vertex Pharmaceuticals Incorporated	3.35%	2,485
10	AMGN	Amgen Inc.	3.14%	3,181
11	GILD	Gilead Sciences, Inc.	3.03%	8,289
12	PFE	Pfizer Inc.	2.94%	44,652
13	REGN	Regeneron Pharmaceuticals, Inc.	2.86%	1,579
14	UTHR	United Therapeutics Corporation	2.73%	1,822
15	JAZZ	Jazz Pharmaceuticals plc	2.51%	3,741
16	INCY	Incyte Corporation	2.46%	7,648
17	ILMN	Illumina, Inc.	2.15%	4,088
18	ZTS	Zoetis Inc.	1.92%	9,417
19	EXEL	Exelixis, Inc.	1.78%	11,488
20	CRL	Charles River Laboratories International, Inc.	1.51%	2,377
21	PTCT	PTC Therapeutics, Inc.	1.48%	6,091
22	NBIX	Neurocrine Biosciences, Inc.	1.44%	2,939
23	MEDP	Medpace Holdings, Inc.	1.40%	966
24	ALKS	Alkermes plc	1.37%	9,366
25	HALO	Halozyme Therapeutics, Inc.	1.19%	5,593

Showing 25 of 51 holdings

Subscribe to see the full list

Activate Now

As of Jul 9, 2026